|
MOAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63846713974181E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
4.05059999986079E-07 |
| Normal-vs-Stage3 |
1.162690E-04 |
| Normal-vs-Stage4 |
5.206100E-02 |
| Stage1-vs-Stage2 |
6.499000E-01 |
| Stage1-vs-Stage3 |
9.590000E-02 |
| Stage1-vs-Stage4 |
2.811400E-01 |
| Stage2-vs-Stage3 |
3.468600E-01 |
| Stage2-vs-Stage4 |
3.558600E-01 |
| Stage3-vs-Stage4 |
8.106800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62481139653892E-12 |
| Normal-vs-AfricanAmerican |
6.12219996920516E-09 |
| Normal-vs-Asian |
2.790600E-01 |
| Caucasian-vs-AfricanAmerican |
2.506200E-01 |
| Caucasian-vs-Asian |
5.171000E-01 |
| AfricanAmerican-vs-Asian |
6.454400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.626032641866E-12 |
| Normal-vs-Female |
1.92360016804116E-10 |
| Male-vs-Female |
4.939000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.13050002692461E-09 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
4.64410000455828E-08 |
| Normal-vs-Extreme_Obese |
3.65300000026991E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.980200E-01 |
| Normal_Weight-vs-Obese |
2.967400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.967000E-01 |
| Extreme_Weight-vs-Obese |
2.340400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.913800E-01 |
| Obese-vs-Extreme_Obese |
2.593800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.761180E-01 |
| Normal-vs-Age(41-60Yrs) |
2.32279973033656E-10 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.58720003806678E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.491500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.806380E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.342100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.616900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.231850E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.564000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
4.70670169505638E-11 |
| Normal-VS-KIRP CIMP |
7.840000E-01 |
| Normal-VS-Unclassified PRCC |
6.95260005123544E-09 |
| Type1 PRCC-VS-Type2 PRCC |
4.149400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.494490E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.575400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.176100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.649200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.376400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.55759907381071E-11 |
| Normal-vs-N1 |
2.517800E-02 |
| Normal-vs-N2 |
2.10399999999167E-05 |
| N0-vs-N1 |
4.518400E-02 |
| N0-vs-N2 |
2.642400E-01 |
| N1-vs-N2 |
1.166760E-01 |
|
|
